Molecules 2009-01-01

Rhodanineacetic acid derivatives as potential drugs: preparation, hydrophobic properties and antifungal activity of (5-arylalkylidene-4-oxo-2-thioxo-1,3-thiazolidin-3-yl)acetic acids.

Jan Dolezel, Petra Hirsova, Veronika Opletalova, Jiri Dohnal, Vejsova Marcela, Jiri Kunes, Josef Jampilek

Index: Molecules 14(10) , 4197-212, (2009)

Full Text: HTML

Abstract

Some [(5Z)-(5-arylalkylidene-4-oxo-2-thioxo-1,3-thiazolidin-3-yl)]acetic acids were prepared as potential antifungal compounds. The general synthetic approach to all synthesized compounds is presented. Lipophilicity of all the discussed rhodanine-3-acetic acid derivatives was analyzed using a reversed phase high performance liquid chromatography (RP-HPLC) method. The procedure was performed under isocratic conditions with methanol as an organic modifier in the mobile phase using an end-capped non-polar C(18) stationary RP column. The RP-HPLC retention parameter log k (the logarithm of the capacity factor k) is compared with log P values calculated in silico. All compounds were evaluated for antifungal effects against selected fungal species. Most compounds exhibited no interesting activity, and only {(5Z)-[4-oxo-5-(pyridin-2- ylmethylidene)-2-thioxo-1,3-thiazolidin-3-yl]}acetic acid strongly inhibited the growth of Candida tropicalis 156, Candida krusei E 28, Candida glabrata 20/I and Trichosporon asahii 1188.

Related Compounds

  • Epalrestat

Related Articles:

Inhibitor selectivity between aldo–keto reductase superfamily members AKR1B10 and AKR1B1: Role of Trp112 (Trp111)

2013-11-15

[FEBS Lett. 587(22) , 3681-6, (2013)]

Docking and molecular dynamics studies toward the binding of new natural phenolic marine inhibitors and aldose reductase

2009-01-01

[J. Mol. Graph. Model. 28(2) , 162-9, (2009)]

6,7-Dihydroxy-4-phenylcoumarin as inhibitor of aldose reductase 2.

2010-10-01

[Bioorg. Med. Chem. Lett. 20 , 5630-3, (2010)]

Inhibitory activities of prenylated flavonoids from Sophora flavescens against aldose reductase and generation of advanced glycation endproducts.

2008-09-01

[J. Pharm. Pharmacol. 60(9) , 1227-36, (2008)]

Epalrestat. A review of its pharmacology, and therapeutic potential in late-onset complications of diabetes mellitus.

1993-01-01

[Drugs Aging 3(6) , 532-55, (1993)]

More Articles...